Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.

doi:10.1111/j.1478-3231.2011.02693.x

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Back to search

Article

Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.

Liver international : official journal of the International Association for the Study of the Liver - 1 May 2012

Park Hana, Lee Jung Min, Seo Ju Hee, Kim Hyon Suk, Ahn Sang Hoon, Kim Do Young, Han Kwang-Hyub, Chon Chae Yoon, Park Jun Yong

Abstract excerpt

BACKGROUND/AIMS: Hepatitis B virus surface antigen (HBsAg) quantification has been suggested to discriminate inactive carriers from hepatitis e antigen (HBeAg) negative chronic hepatitis, but it could be genotype-dependent. We studied the predictive value of HBsAg quantification in genotype C HBeAg-negative hepatitis B virus (HBV) carriers. METHODS: We recruited 104 HBeAg-negative HBV carriers with HBV DNA...

Topics

Adult
Aged
Area Under Curve
Biomarkers
Carrier State
DNA, Viral
Female
Genotype
Hepatitis B Surface Antigens
Hepatitis B e Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Hepatitis B virus

Hepatitis B, Chronic

Humans

Male

Middle Aged

Predictive Value of Tests

Prognosis

Prospective Studies

Source

Open in PubMed

Identifiers

PMID: 22128792
DOI: 10.1111/j.1478-3231.2011.02693.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.PMID 22128792Read ↗

Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype.Semantic proximity Read ↗

Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.Semantic proximity Read ↗

Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.Semantic proximity Read ↗

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.Semantic proximity Read ↗

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.Semantic proximity Read ↗

Serum hepatitis B virus DNA levels differentiating inactive carriers from patients with chronic hepatitis B.Semantic proximity Read ↗

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B.Semantic proximity Read ↗

Distinct seromarkers predict different milestones of chronic hepatitis B progression.Semantic proximity Read ↗

Predictive Factors for HBsAg Loss in Chronic HBeAg-Negative Hepatitis B Virus Infection: Insights From a 5-Year French Cohort.Semantic proximity Read ↗

HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.Semantic proximity Read ↗

A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection.Semantic proximity Read ↗

Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.